Recurrent in-frame insertion in C/EBPalpha TAD2 region is a polymorphism without prognostic value in AML.
Biggio
V
V
Renneville
A
A
Nibourel
O
O
Philippe
N
N
Terriou
L
L
Roumier
C
C
Amouyel
P
P
Cottel
D
D
Castaigne
S
S
Dombret
H
H
Thomas
X
X
Fenaux
P
P
Preudhomme
C
C
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000235:genetics*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D016254:Mutagenesis, Insertional; D009363:Neoplasm Proteins / Q000235:genetics*; D011110:Polymorphism, Genetic; D011379:Prognosis; D017434:Protein Structure, Tertiary; D012306:Risk; D016019:Survival Analysis
D022763:CCAAT-Enhancer-Binding Protein-alpha; D009363:Neoplasm Proteins